摘要
目的:探讨HBsAg阳性肝病患者合并HCV感染后对肝脏病变的影响以及血清中HCV存在的形式。方法:被测对象为168例HBsAg阳性肝病患者(肝炎后肝硬化104例,原发性肝细胞癌64例),采用逆转录-聚合酶链反应(RT-PCR)检测血清中HCVRNA,采用免疫沉定法判断HCV在血清中存在的形式。结果:HBsAg阳性肝病患者合并HCV感染者为20.8%,与无HBV感染人群HCV感染率2.2%比较有显著性差异。HCV在血清中的存在形式77%呈游离状态,23%既有游离状态,又有免疫复合物的形式。HBsAg阳性脏病患者合并HCV感染者肝功能损害明显加重,肝癌并发率为26.6%。
Objective:This paper was to study the influence of HCV infection on the liver function of patients with HBsAg positive liver diseases, and the existing form of HCV in sera. [WT5”HZ〗Methods:[WT5”BZ〗Total of 168 patients with HBsAg positive liver diseases were studied. HCV RNA and the existing HCV forms in sera were determined with reverse transcriptionpolymerse chain reaction(RTPCR) and immunoprecipitation method respectively.[WT5”HZ〗Results:The[KG2〗incidenceof HCV infection in HBsAg positivepatients was 20.8%, which was higher than that(2.2%) of people without HBV infection. In 77%(27/35) patients, the HCV was in free form and in 23%(8/35) patients,the HCV was in both free and immunocomplex forms in sera. The liver functions were severely damaged and the hepatocarcinoma incidence was high(26.6%) in patients with combinated HBV and HCV infection.Conclusions:The findings suggest that the severe damage of liver function and the high incidence of hepatocarcinoma were closely related to the synergistic action of HBV and HCV.
出处
《中国医科大学学报》
CAS
CSCD
北大核心
1998年第4期387-390,共4页
Journal of China Medical University